Stay updated on Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.

Latest updates to the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe site revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference0.9%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1, reflecting a site software update.SummaryDifference0.1%

- Check55 days agoChange DetectedThe record history now includes a new revision labeled v3.7.0, indicating the study record has been updated. The previous revision v3.6.6 is no longer listed in the history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe study record history shows a new revision entry: v3.6.6 was added and the previous revision v3.6.5 was removed. This update represents an updated version of the page's revision history.SummaryDifference0.1%

- Check90 days agoChange DetectedThe History page now shows Revision: v3.6.5, replacing the previous v3.6.4, reflecting a software revision of the page history interface.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo with Carfilzomib in Myeloma Clinical Trial page.